Results 201 to 210 of about 832,216 (359)

An Individualized Approach of Multidisciplinary Heart Team for Myocardial Revascularization and Valvular Heart Disease-State of Art. [PDF]

J Pers Med, 2022
Jonik S, Marchel M, Huczek Z, Kochman J, Wilimski R, Kuśmierczyk M, Grabowski M, Opolski G, Mazurek T.   +8 more
europepmc   +1 more source

'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.

European Heart Journal, 2019
F. Neumann, M. Sousa‐Uva
semanticscholar   +1 more source

INTRAVENOUS LABETALOL FOR BLOOD PRESSURE REDUCTION FOLLOWING MYOCARDIAL REVASCULARIZATION [PDF]

, 1987
Donald S. Prough, Stephen A. Mills, James Kiger, David L. Bowton   +3 more
openalex   +1 more source

Effectiveness of home-rehabilitation in patients after an acute coronary syndrome and myocardial revascularization. [PDF]

Int J Cardiol Cardiovasc Risk Prev, 2022
Werren M, Valent F, Di Chiara A.
europepmc   +1 more source

Risk factors and late recurrence of angina following myocardial revascularization [PDF]

, 1982
P. E. Schackman, Virinderjit S. Bamrah, Felix E. Tristani, J. J. Barboriak, C. V. Hughes, Donal H. Pedersen, Alfred J. Anderson   +6 more
openalex   +1 more source

Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

European Journal of Heart Failure, EarlyView.
Prevalence and predictors of, and outcome associated with history of cancer in patients with heart failure. AF, atrial fibrillation; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CV, cardiovascular; DM, diabetes mellitus; EF, ejection fraction; GDMT, guideline‐directed medical therapy; GI, gastrointestinal; Hb, haemoglobin; HF ...
Pietro Ameri, Paolo Costa, Lina Benson, Davide Stolfo, Nabil V. Sayour, Charlotta Ljungman, Javed Butler, Stefan D. Anker, Nicolas Girerd, Kalliopi Keramida, Gerasimos Filippatos, Lars H. Lund, Felix Lindberg, Gianluigi Savarese   +13 more
wiley   +1 more source

SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization-A Powerful Reminder and Call to Action. [PDF]

J Soc Cardiovasc Angiogr Interv, 2022
Vogel B, Bairey Merz CN, Mehran R.
europepmc   +1 more source

Myocardial Revascularization

, 1978
George C. Kaiser, Hendrick B. Barner, Denis H. Tyras, John E. Codd, J. Gerard Mudd, Vallee L. Willman   +5 more
openalex   +2 more sources

Prognostic significance of somatic mutations in myeloid cells of men with chronic heart failure – interaction between loss of Y chromosome and clonal haematopoiesis

European Journal of Heart Failure, EarlyView.
Abstract Aims Age‐associated clonal haematopoiesis of indeterminate potential (CHIP) has been linked to increased incidence and worse prognosis of chronic heart failure (CHF). CHIP arises from somatic mutations in haematopoietic stem and progenitor cells. Mosaic loss of Y chromosome (LOY), the most common somatic mutation in male blood cells, increases
Sebastian Cremer, Moritz von Scheidt, Klara Kirschbaum, Lukas Tombor, Silvia Mas‐Peiro, Wesley Abplanalp, Tina Rasper, Akshay Ware, Andrin Schuff, Alexander Berkowitsch, Johannes Krefting, David Leistner, Heribert Schunkert, Thimoteus Speer, Stefanie Dimmeler, Andreas Michael Zeiher   +15 more
wiley   +1 more source

Impact of myocardial revascularization on long-term outcomes in a nationwide cohort of first acute myocardial infarction survivors. [PDF]

Eur Heart J Suppl, 2022
De Luca L, D'Errigo P, Rosato S, Mureddu GF, Badoni G, Seccareccia F, Baglio G.   +6 more
europepmc   +1 more source